De-risk Go/No Go Product Development Decisions by Reusing Patient Trial Data
White Paper
De-risk Go/No Go Product Development Decisions by Reusing Patient Trial Data
Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist disease learning and future trial planning, and synthetic control arms provide precise data for confident interpretation of uncontrolled trials.